Despite aggressive limb salvage techniques, lower extremity amputation (LEA) is frequently performed. Major indications for LEA include ischemia and uncontrolled infection (UI). A review of the national Vascular Quality Initiative amputation registry was performed to analyze the influence of indication on outcomes after LEA. Retrospective review of the Vascular Quality Initiative LEA registry (2012–2017) identified all above- and below-knee amputations. Outcome measures included 30-day mortality, return to operating room (OR), postoperative myocardial infarctions, and postoperative SSI. Indications for surgery included ischemic rest pain, ischemic tissue loss (TL), acute limb ischemia (ALI), UI, and neuropathic TL. A total of 6701 patients met the inclusion criteria. The indications for surgery included TL (49.0%), UI (31.7%), ALI (8.0%), rest pain (6.6%), and neuropathic TL (2.3%). Patients with ALI had the highest 30-day mortality (12.0%) compared with TL (6.6%) and UI (6.4%) [P < 0.001]. The highest rate of return to OR occurred in the UI group (12.6%) [P < 0.001]. Multivariate analysis demonstrated that patients with UI have significantly higher rates of return to OR, whereas those with ALI have a 30-day mortality twice as high as other indications (both P < 0.001). These data can inform expectations after LEA based on the indications for surgery.
Get full access to this article
View all access options for this article.
References
1.
SidawyA.N., PerlerB.A.Rutherford's Vascular Surgery and Endovascular Therapy, 9th Ed.Philadelphia, PA: Elsevier, 2019.
2.
DormandyJ.A., RutherfordR.B.Management of peripheral arterial disease (PAD). TASC working group. TransAtlantic Inter-Society Consensus (TASC).J Vasc Surg2000; 31: S1–296.
3.
AulivolaB., HileC.N., HamdanA.D.Major lower extremity amputation: outcome of a modern series.Arch Surg2004; 139: 395–9; discussion 399.
4.
TaylorS.M., KalbaughC.A., CassA.L.“Successful outcome” after below-knee amputation: an objective definition and influence of clinical variables.Am Surg2008; 74: 607–12; discussion 612–3.
5.
ConteM.S., BandykD.F., ClowesA.W.Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.J Vasc Surg2005; 42: 456–64; discussion 464–5.
6.
JonesW.S., PatelM.R., DaiD.High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease.Am Heart J2013; 165: 809–15, 815.e801.
7.
DiehmC., AllenbergJ.R., PittrowD.Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease.Circulation2009; 120: 2053–61.
8.
RookeT.W., HirschA.T., MisraS.2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline).Vasc Med2011; 16: 452–76.
9.
JonesW.S., PatelM.R., DaiD.Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000–2008.J Am Coll Cardiol2012; 60: 2230–6.
10.
ReineckeH., UnrathM., FreisingerE.Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence.Eur Heart J2015; 36: 932–8.
11.
NorgrenL., HiattW.R., DormandyJ.A.Inter-society consensus for the management of peripheral arterial disease (TASC II).J Vasc Surg2007; 45: S5–67.
12.
LaydenJ., MichaelsJ., BerminghamS.Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance.BMJ2012; 345: e4947.
13.
GoodneyP.P., BeckA.W., NagleJ.National trends in lower extremity bypass surgery, endovascular interventions, and major amputations.J Vasc Surg2009; 50: 54–60.
14.
VierthalerL., CallasP.W., GoodneyP.P.Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia.J Vasc Surg2015; 62: 655–64, e658.
15.
CruzC.P., EidtJ.F., CappsC.Major lower extremity amputations at a Veterans Affairs hospital.Am J Surg2003; 186: 449–54.
16.
KhuriS.F., DaleyJ., HendersonW.The Department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program.Ann Surg1998; 228: 491–507.
17.
AielloF.A., ShueB., KiniN.Outcomes reported by the vascular quality initiative and the National Surgical Quality Improvement Program are not comparable.J Vasc Surg2014; 60: 152–9, 159.e151–153.
18.
GabelJ., JaboB., PatelS.Analysis of patients undergoing major lower extremity amputation in the vascular quality initiative.Ann Vasc Surg2018; 46: 75–82.
19.
BelmontP.J., DaveyS., OrrJ.D.Risk factors for 30-day postoperative complications and mortality after below-knee amputation: a study of 2,911 patients from the National Surgical Quality Improvement Program.J Am Coll Surg2011; 213: 370–8.
20.
CurranT., ZhangJ.Q., LoR.C.Risk factors and indications for readmission after lower extremity amputation in the American College of Surgeons National Surgical Quality Improvement Program.J Vasc Surg2014; 60: 1315–24.
